These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12446612)

  • 1. Effect of chronic treatment with bovine recombinant growth hormone on cardiac dysfunction and lesion progression in UM-X7.1 cardiomyopathic hamsters.
    Marleau S; Lapointe N; Massicotte J; Céméus C; Jasmin G; Dumont L; Sirois MG; Rouleau JL; Du Souich P; Ong H
    Endocrinology; 2002 Dec; 143(12):4846-55. PubMed ID: 12446612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters.
    Ueyama T; Ohkusa T; Yano M; Matsuzaki M
    Cardiovasc Res; 1998 Oct; 40(1):64-73. PubMed ID: 9876318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters.
    Iwase M; Kanazawa H; Kato Y; Nishizawa T; Somura F; Ishiki R; Nagata K; Hashimoto K; Takagi K; Izawa H; Yokota M
    Cardiovasc Res; 2004 Jan; 61(1):30-8. PubMed ID: 14732199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
    Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
    Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in cardiac SR Ca(2+)-release channels during development of heart failure in cardiomyopathic hamsters.
    Ueyama T; Ohkusa T; Hisamatsu Y; Nakamura Y; Yamamoto T; Yano M; Matsuzaki M
    Am J Physiol; 1998 Jan; 274(1):H1-7. PubMed ID: 9458845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster.
    Villame J; Massicotte J; Jasmin G; Dumont L
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):41-8. PubMed ID: 11504162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
    Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
    Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disorder in cardiomyopathic hamsters.
    Togari A; Arai M; Matsumoto S; Tarumoto Y; Takahashi H
    Bone Miner; 1989 Sep; 7(2):127-36. PubMed ID: 2529935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of carvedilol improves cardiac function in 6-month-old Syrian cardiomyopathic hamsters.
    Cruz N; Arocho L; Rosario L; Crespo MJ
    Pharmacology; 2007; 80(2-3):144-50. PubMed ID: 17534124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters.
    Massicotte J; Viens A; Yao MH; Leonardi A; Sironi G; Wang H; Dumont L
    Acta Pharmacol Sin; 2003 Mar; 24(3):199-206. PubMed ID: 12617766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
    Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
    Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters.
    Dixon IM; Hao J; Reid NL; Roth JC
    Cardiovasc Res; 2000 May; 46(2):286-97. PubMed ID: 10773233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age related changes in contractility and alpha 1 adrenergic responsiveness of myocardium from normal hamsters and hamsters with hereditary cardiomyopathy.
    Li K; Rouleau JL
    Cardiovasc Res; 1993 Jun; 27(6):968-73. PubMed ID: 8221787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased left ventricular diastolic stiffness in the early phase of hereditary cardiomyopathy.
    Kapelko VI; Parmley WW; Wu S; Stone RD; Jasmin G; Wikman-Coffelt J
    Am Heart J; 1988 Sep; 116(3):765-70. PubMed ID: 3414491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in adhesion junction precede gap junction remodelling during the development of heart failure in cardiomyopathic hamsters.
    Yoshida M; Ohkusa T; Nakashima T; Takanari H; Yano M; Takemura G; Honjo H; Kodama I; Mizukami Y; Matsuzaki M
    Cardiovasc Res; 2011 Oct; 92(1):95-105. PubMed ID: 21693625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of growth hormone-releasing peptide on myocardial oxidative stress and left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Kato Y; Iwase M; Ichihara S; Kanazawa H; Hashimoto K; Noda A; Nagata K; Koike Y; Yokota M
    Circ J; 2010 Jan; 74(1):163-70. PubMed ID: 19942785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
    Nakamura Y; Ryoke T; Tanaka N; Ohkusa T; Matsuzaki M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):171-8. PubMed ID: 9475257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.